Atropos Health, a leader in transforming real-world clinical data into personalized real-world evidence (RWE), has announced the appointment of Kevin Smith as its new Chief Growth Officer, effective immediately. Smith, who previously led key functions within the company’s commercial team, will now spearhead new business development for both health systems and life science organizations, as well as drive the broader adoption of Atropos Health’s agentic solutions for clinical decision support. The appointment comes amid a period of rapid growth for the company. Following the successful launch of the Atropos Evidence™ Agent and expanded integrations with major cloud platforms including Microsoft, AWS, and Google Cloud, demand for Atropos Health’s AI-powered insights has surged. Organizations across the healthcare spectrum are increasingly seeking high-quality, patient-specific evidence delivered in seconds. Smith brings over 20 years of experience in health technology, with a proven track record in scaling commercial operations and leading digital transformation initiatives. Before joining Atropos Health, he held senior leadership roles at prominent industry players, including Oracle (Cerner) and Accenture, where he focused on leveraging data and analytics to improve healthcare delivery. “Kevin’s leadership has been a cornerstone of our commercial success over the past year,” said Dr. Brigham Hyde, CEO and Co-Founder of Atropos Health. “As we move into 2026, the industry is shifting from AI experimentation to full-scale integration. Kevin’s deep understanding of complex healthcare ecosystems and his vision for the future of evidence-based medicine make him the ideal leader to guide our next phase of growth. Under his leadership, we will continue to close the evidence gap for clinicians and researchers around the world.” In his new role, Smith will focus on accelerating the expansion of Atropos Health’s AI solutions, working to establish the company’s platform as the standard operating system for real-world evidence across the entire healthcare continuum. “I am honored and energized to take on this role at such a pivotal moment for Atropos Health,” said Smith. “We’ve proven that our technology can address one of healthcare’s most pressing challenges—the lack of timely, personalized evidence at the point of care. My focus will be on increasing our market velocity and deepening partnerships with life science companies and health systems. We’re not just building a tool; we’re building the infrastructure that makes evidence-based medicine a reality for every patient.” The promotion underscores Atropos Health’s commitment to high-performance execution as it continues to lead the way in AI adoption and real-world evidence generation. Atropos Health is the developer of GENEVA OS®, the operating system for rapid healthcare evidence across a vast network of real-world data. The company partners with healthcare and life science organizations to close evidence gaps from research to patient care, improve individual outcomes through data-driven decisions, and accelerate medical discovery. Atropos Health is on a mission to transform healthcare by delivering timely, relevant, and actionable real-world evidence. For more information, visit www.atroposhealth.com or connect via LinkedIn or X (Twitter).